Juno jumps on cancer therapy wave
But the journey to commercialising the bespoke medication remains daunting
Minneapolis
IT'S a cancer therapy straight out of Greek mythology, bespoke medicine with astonishing results in the smallest and sickest of patients.
The treatment, called a chimeric antigen receptor, or CAR for short, has captured the attention of the biggest drug companies and become a hotbed for biotechnology startups. A medical amalgam like the chimera in Homer's Iliad - a fire- breathing monster with a lion's head, a goat's body and a snake's tail - it may offer the best chance for patients like toddler Greta Oberhofer to beat acute lymphoblastic leukemia.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue